Relationship of predialytic intact parathyroid hormone on secondary hyperparathyroidism in chronic maintenance haemodialysis patients

被引:1
|
作者
Etoh, S
Murata, T
Hasegawa, Y
Miyahara, Y
Ishimura, A
Abe, Y
Noda, R
Ogahara, S
Kaneoka, H
Saito, T
机构
[1] Fukuoka Univ, Sch Med, Dept Internal Med, Div Nephrol & Rheumatol,Jonan Ku, Fukuoka 8140180, Japan
[2] Kawanami Hosp Kidney Ctr, Fukuoka, Japan
关键词
haemodialysis; intact-parathyroid hormone; parathyroid ultrasonography; predialysis; risk factor; secondary hyperparathyroidism;
D O I
10.1111/j.1440-1797.2004.00248.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Methods and Results: In order to clarify the predialytic factors influencing the onset of secondary hyperparathyroidism (SHPT) in patients on chronic maintenance haemodialysis, the time-course changes of serum levels of intact-PTH (i-PTH) during haemodialysis for 5 years were investigated. The subjects were 69 non-diabetic patients who had a serum aluminium level of less than 1.85 nmol/L at the end of observation. Patients were divided into two groups based on i-PTH levels obtained at the start of dialysis; the high group (H group) consisted of patients whose i-PTH levels were more than 22.00 pmol/L, the low group (L group) had levels less than 22.00 pmol/L. In the H group, i-PTH was 41.46 +/- 2.87 pmol/L at the start of dialysis (vs L group, P < 0.0001) and 15.82 +/- 2.85 pmol/L after haemodialysis initiation. In the L group, i-PTH levels did not significantly change and was 11.69 +/- 2.50 pmol/L 12 months after the start of dialysis (at the 12th month). However, at the 60th month, the i-PTH level was 33.24 +/- 5.30 pmol/L in the H group, and 9.85 +/- 2.13 pmol/L in the L group (P < 0.005). Conclusion: It is suggested that control of i-PTH levels in the predialytic period may be important to suppress SHPT throughout haemodialysis.
引用
收藏
页码:161 / 166
页数:6
相关论文
共 50 条
  • [21] Comparison of intact and whole parathyroid hormone levels after parathyroidectomy between patients with primary and secondary hyperparathyroidism.
    Yamashita, H
    Gao, P
    Noguchi, S
    Uchino, S
    Watanabe, S
    Ogawa, T
    Fukagawa, M
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S100 - S100
  • [22] Serum intact parathyroid hormone in diabetic patients on haemodialysis: what is the treatment goal
    Gnudi, Luigi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (01) : 24 - 26
  • [23] The relationship between total mass and blood supply of parathyroid glands and their secretion of parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism
    Ahmadi, Farrokhlagha
    Aghajanzadeh, Pegah
    Yazdi, Hadi Rokni
    Maziar, Sima
    Gatmiri, Sayad Mansour
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2016, 27 (02) : 263 - 269
  • [24] Relationship Between Aldosterone And Parathyroid Hormone In Patients With Primary Hyperparathyroidism
    Stanic, Branka
    Ilincic, Branislava
    Zeravica, Radmila
    Milicic-Ivanovski, Dragana
    Cabarkapa, Velibor
    Mijovic, Romana
    HYPERTENSION, 2021, 78
  • [25] Circulating forms of parathyroid hormone detected with an immunofluorometric assay in patients with primary hyperparathyroidism and in hyperparathyroidism secondary to chronic renal failure
    Kunii, IS
    Vieira, JGH
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2001, 34 (12) : 1547 - 1550
  • [26] MEASUREMENT OF INTACT PARATHYROID-HORMONE IN THE DIAGNOSIS OF HYPERPARATHYROIDISM
    BERGENFELZ, A
    VALDERMARSSON, S
    AHREN, B
    ACTA ENDOCRINOLOGICA, 1991, 125 (06): : 668 - 674
  • [27] Can the use of intraoperative intact parathyroid hormone monitoring be abandoned in patients with hyperparathyroidism?
    Sakimura, Chika
    Minami, Shigeki
    Hayashida, Naomi
    Uga, Tatsuya
    Inokuchi, Naoko
    Eguchi, Susumu
    AMERICAN JOURNAL OF SURGERY, 2013, 206 (04): : 574 - 577
  • [28] Relationship between parathyroid hormone and renin-angiotensin-aldosterone system in hemodialysis patients with secondary hyperparathyroidism
    Kono, Keiji
    Fujii, Hideki
    Watanabe, Kentaro
    Goto, Shunsuke
    Nishi, Shinichi
    JOURNAL OF BONE AND MINERAL METABOLISM, 2021, 39 (02) : 230 - 236
  • [29] Sequential changes in plasma intact and whole parathyroid hormone levels during parathyroidectomy for secondary hyperparathyroidism
    Yamashita, H
    Cantor, T
    Uchino, S
    Watanabe, S
    Ogawa, T
    Moriyama, T
    Takamatsu, Y
    Fukagawa, M
    Noguchi, S
    WORLD JOURNAL OF SURGERY, 2005, 29 (02) : 169 - 173
  • [30] Anti-parathyroid treatment effectiveness and persistence in incident haemodialysis patients with secondary hyperparathyroidism
    Martin de Francisco, Angel Luis
    Gillespie, Iain Andrew
    Gioni, Ioanna
    Floege, Juergen
    Kronenberg, Florian
    Marcelli, Daniele
    Wheelers, David Collins
    Froissart, Marc
    Drueke, Tilman Bernhard
    NEFROLOGIA, 2016, 36 (02): : 164 - 175